SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001424422-19-000002
Filing Date
2019-02-21
Accepted
2019-02-21 18:26:27
Documents
1
Period of Report
2019-02-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 2051
  Complete submission text file 0001424422-19-000002.txt   3457
Mailing Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025
Business Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025 650-889-5020
BioPharmX Corp (Issuer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1579 MAIN ST SOUTHLAKE TX 76092
Business Address
Plott Ronald Todd (Reporting) CIK: 0001768337 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37411 | Film No.: 19623361